We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$492B
AUM Growth
+$21.5B
Cap. Flow
-$6.18B
Cap. Flow %
-1.26%
Top 10 Hldgs %
30.05%
Holding
13,811
New
1,371
Increased
4,862
Reduced
5,559
Closed
1,866

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.23%
2 Technology 2.7%
3 Consumer Discretionary 1.66%
4 Financials 1.18%
5 Communication Services 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POL
11151
DELISTED
Polished.com Inc.
POL
$67.5K ﹤0.01%
2,937
-963
-25% -$23.3K
AKU
11152
DELISTED
Akumin Inc
AKU
$67.3K ﹤0.01%
+374,081
New +$171K
TBIO
11153
CALL
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$67.2K ﹤0.01%
2,361
+1,183
+100% +$47.2K
AMPE
11154
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$66.6K ﹤0.01%
14,480
BKSY icon
11155
PUT
BlackSky Technology
BKSY
$1.01B
$66.6K ﹤0.01%
3,750
-3,013
-45% -$36K
BGRY
11156
CALL
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$66.6K ﹤0.01%
47,200
-84,500
-64% -$117K
MIST icon
11157
Milestone Pharmaceuticals
MIST
$148M
$66.3K ﹤0.01%
23,261
+10,875
+88% +$41K
QUAD icon
11158
Quad
QUAD
$518M
$66.2K ﹤0.01%
17,594
-34,375
-66% -$124K
LFMD icon
11159
PUT
LifeMD
LFMD
$157M
$66.1K ﹤0.01%
+15,200
New +$33.8K
QNTM
11160
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$131
$66.1K ﹤0.01%
884
+347
+65% +$29.8K
NMRK icon
11161
CALL
Newmark Group
NMRK
$2.82B
$65.9K ﹤0.01%
+10,600
New +$65.3K
BIOR
11162
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$65.7K ﹤0.01%
1,706
+623
+58% +$22K
GWH icon
11163
ESS Tech
GWH
$14.1M
$65.5K ﹤0.01%
2,970
+196
+7% +$3.54K
CRBU icon
11164
CALL
Caribou Biosciences
CRBU
$178M
$65K ﹤0.01%
15,300
+3,200
+26% +$14.4K
AZRE
11165
DELISTED
Azure Power Global Limited
AZRE
$64.9K ﹤0.01%
36,674
+9,728
+36% +$21.3K
FEAM icon
11166
5E Advanced Materials
FEAM
$70.6M
$64.8K ﹤0.01%
859
-1,093
-56% -$104K
BLUE
11167
CALL
DELISTED
bluebird bio
BLUE
$64.8K ﹤0.01%
985
-3,350
-77% -$245K
BNGO icon
11168
PUT
Bionano Genomics
BNGO
$14.3M
$64.7K ﹤0.01%
177
-244
-58% -$110K
RGLS
11169
CALL
DELISTED
Regulus Therapeutics
RGLS
$64.7K ﹤0.01%
44,000
+3,300
+8% +$4.4K
RAIL icon
11170
CALL
FreightCar America
RAIL
$237M
$64.7K ﹤0.01%
21,700
-2,200
-9% -$6.36K
RLX icon
11171
RLX Technology
RLX
$2.2B
$64.6K ﹤0.01%
36,523
-1,011,867
-97% -$2.26M
SPRO icon
11172
Spero Therapeutics
SPRO
$70.5M
$64.3K ﹤0.01%
44,359
+17,815
+67% +$30.5K
PIM
11173
Franklin Master Intermediate Income Trust
PIM
$153M
$64.1K ﹤0.01%
20,275
-17,773
-47% -$56K
HFFG icon
11174
HF Foods Group
HFFG
$97M
$63.8K ﹤0.01%
13,605
-3,157
-19% -$12.4K
AMPG icon
11175
AmpliTech
AMPG
$112M
$63.5K ﹤0.01%
27,472
+11,684
+74% +$31.9K

Similar funds

Jeff Yass's Q2 2023 Portfolio in Review

As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
  • Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
  • Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
  • Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
  • Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.